Caerin 1.1 Modification
General Information
DCTPep ID DCTPep06861
Peptide Name Caerin 1.1 Modification
Sequence GLLSVLGSVAKHVLGHVVGVIAEHL
Sequence Length 25
UniProt ID Not available
PubChem CID Not available
Origin Synthetic
Type Synthetic peptide
Classification
Cancer therapy related peptides
Activity Information
Hemolytic Activity Not available
Normal (non-cancerous) Cytotoxicity Not available
Target Not available
Affinity Not available
Mechanism Not available
Structure Information
PDB ID Not available
Predicted Structure Not available
(Please note that there is the predicted structure, predicted by AlphaFold)
Helicity Not available
Linear/Cyclic Linear
Disulfide/Other Bond Not available
N-terminal Modification Free
C-terminal Modification Amidation
Other Modification None
Chiral L
Physicochemical Information
Formula C115H194N32O30
Absent amino acids CDFMNPQRTWY
Theoretical pI 7.02
Acidic residues 1
Basic residues 4
Polar residues 6
Molecular weight (Average) 2505
Molecular weight (Monoisotopic) 2503.46
Common amino acids V
Net charge 3
Instability index (II) 3.19
Aliphatic index 171.20
Grand average of hydropathicity (GRAVY) 1.284
Half Life
30 hours (mammalian reticulocytes, in vitro).
>20 hours (yeast, in vivo).
>10 hours (Escherichia coli, in vivo).
Extinction coefficients
Should not be visible by UV spectrophotometry.
Amino acid distribution
Literature Information
Literature 1
Pubmed ID 15203252
Title Host-defence peptides of Australian anurans: structure, mechanism of action and evolutionary significance
Doi Not available
Year 2004
Patent
Patent ID Not available
Patent Title Not available
Other Iinformation Not available
Other Published ID Not available